- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05768516
Can we Improve Care Pathway in Low Back Pain? (DeltaDos)
Can we Improve Care Pathway in Low Back Pain? A Pilot Study
The general objective of this pilot study is to investigate a new multi-level intervention in primary care to improve the care of patients with low back pain. Specifically, it will first investigate the feasibility of delivering this intervention in primary care in Switzerland. Second, it will evaluate the effectiveness of the intervention on the use of unnecessary imaging and unhelpful medication in primary care, the risk of developing chronic disabling care, and direct and indirect healthcare costs.
In this two-arm parallel pilot study, it is the general practitioners that will be recruited to be in either arm. In the intervention group, they will deliver the multi-level intervention that consists of:
- Stratifying care based on the risk of chronicity
- Improving healthcare professional education
- Improving patient education
- Facilitating interprofessional communication
General practitioners in the control group will have no specific training or intervention. They will treat patients according to their usual practice.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study aims to investigate a multi-level intervention in primary care to improve the care of patients with LBP.
In this pilot trial, it is the GPs that will be recruited to be in either arm. Five to seven GPs will be recruited in each study arm. As this is a pilot study, randomization was not felt necessary. To facilitate this pilot study, two health care centers (one for each arm) have been selected for their convenience. GPs from each arm will thus be recruited within the same health care center.
For the development of the intervention, various existing interventions that have been tested successfully elsewhere and had the possibility of being adapted in the context of Switzerland's primary care practice were selected. The investigators used available evidence to develop the multi-level intervention. The different components and the procedures of the multi-level intervention were developed by a team of LBP experts in collaboration with GPs, PTs, and OTs. Various meetings with GPs were conducted to determine the feasibility and their preferences for each component of the intervention.
The overall goal of the intervention is to help GPs provide high-value care, adapt the treatment plan to the risk of chronicity (stratified care), decrease unnecessary healthcare (i.e., unnecessary imaging), and facilitate interprofessional collaboration. The intervention includes the following components:
Stratifying the management of LBP according to risk factors for chronicity with the StartBack tool (SBT) has been shown to improve patient outcomes and reduce unnecessary overtreatment. This stratification into 3 stages, low, medium, and high, is mainly based on the presence of elements such as kinesiophobia and catastrophism. These elements are linked to anxiety, which is often involved in the erroneous prescription of imaging or inappropriate care (e.g. opioids). Thus, by adapting management to psychological factors it is possible to facilitate the reduction of unnecessary care together with the improvement of patients' outcomes. Based on previous work, the investigators developed a simple algorithm to determine the risk level based on the SBT and other variables that have been shown to improve the classification, such as work capacity. Based on the risk level, a management plan is proposed which may include PT.
PTs in the intervention group will all have participated to a one-day course to upgrade their knowledge on good clinical practice in LBP care and get the certification.
- Healthcare professional education. The first component is health practitioners' education to improve their knowledge about LBP guidelines, diagnostic triage, and best practice. Furthermore, they will be trained to improve patients' education (i.e. on reducing the use of imaging), to follow a care strategy based on a questionnaire-based chronicity risk stratification rather than a step-up strategy, and improve interprofessional communication.
- Patient education. Many patients expect to have an MRI of their spine in the belief that it will uncover the source of their problem and define the appropriate treatment. Only through better education can they change their perspective, be reassured of their clinical course without imaging, and understand the utility of staying active. Different strategies will be implemented to reassure patients. First, an education booklet "Understanding My Low Back Pain", which showed promising results in reducing the use of imaging has been translated into French and will be used by GPs during their consultations. Second, GPs, PTs, and OTs will provide similar reassuring messages and direct patients to the website www.infomaldedos.ch, which provides accurate and reassuring messages about LBP.
- Interprofessional collaboration. By improving communication between the different healthcare providers, patients will have access to the right care at the right time and will receive a more consistent and reassuring message about LBP. To this end, a structured assessment form and facilitated contact will be implemented. PTs and OTs will be trained to provide a simple structured report of the patient's progress with a suggestion for further management to the GPs.
The multi-level intervention will be only at the level of the GPs. Prior to the start of the study, GPs will be informed on all aspects of good clinical practice during a specific time dedicated to continuing medical education. This will be done in interactive sessions, starting from their own experience, and implementing specific information when needed. A clinical pathway according to the risk of chronicity and specifically adapted to the Swiss healthcare system will be discussed during two one-hour meetings. The education will be provided by a rheumatologist with internationally recognized experience in the management of LBP. An information meeting will then be held to explain in detail the mechanisms of the study and the different tools that will be provided.
At the time of patient's first consultation for a new episode of back pain, The GP will have access to an interactive specifically designed and validated booklet in French "Understanding My Low Back Pain" to help educate patients that imaging is not recommended and point towards the general principle of good clinical practice care.
After the medical consultation, When the patient returns the signed informed consent form, the medical assistant will tag the patient within the computer system. Five days after the medical consultation the patient will receive an email with a questionnaire including the SBT. GPs will receive via email a summary of the SBT indicating the risk of chronicity (low, medium, or high) and a proposed treatment approach based on stratified care. The risk assessment will be based on the validated SBT with the addition of the ability to work.
In the case of low-risk GP'a are encouraged to focus on information and reassurance, with the help of information on a website. The use of additional treatments should be reduced to a minimum. In the case of medium risk, the proposition will be to prescribe 6 individual sessions of exercise-based physiotherapy. At the end of the 6 sessions, the physiotherapist will provide the GP with a structured report of the patient's progress with a suggestion for further management based on the clinical course: end of treatment, continuation for a few more sessions, or referral for further assessment to consider the need for structured multidisciplinary intervention. In cases of high risk, patients will be referred for 1-2 sessions to a specifically trained occupational therapist to determine if there is a need for immediate integration in a structured multidisciplinary group intervention or if the patient can be treated according to the proposition for medium risk patients. GPs are free to organize the following appointment and treatment plan according to the proposition or not.
Six weeks later, a second email will be sent to the patients with the same set of questionnaires and the updated results, including the updated risk of chronicity, will be sent to the GPs again. GPs may use this information to adapt patient care.
During the entire process, the decision on how to treat the patients is in the hand of the treating GPs. It is his responsibility to follow the recommendation of the proposed clinical pathway or not.
GPs in the control group will have no specific training or intervention. They will treat patients according to their usual practice. The same information will be provided to patients in the informed consent form (i.e. participation in a study on back pain). Patients will receive the same SMS to verify their phone number and then receive the same questionnaire as in the "stratified care" group. However, no feedback will be provided to the GPs.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Stephane Genevay, Prof.
- Phone Number: +41223723311
- Email: stephane.genevay@hcuge.ch
Study Contact Backup
- Name: Guillaume Christe, PhD
- Phone Number: +41213168123
- Email: guillaume.christe@hesav.ch
Study Locations
-
-
Geneva
-
Le Lignon, Geneva, Switzerland, 1219
- Recruiting
- Centre médical Lignon
-
Contact:
- Mélanie Da Fonseca
- Phone Number: 022 796 25 25
- Email: secretariat@cmlignon.ch
-
Principal Investigator:
- Benoit FAvre, MD
-
Onex, Geneva, Switzerland, 1213
- Recruiting
- Centre médical Onex
-
Contact:
- Fanny Berrayah
- Email: fanny.berrayah@cpo.ch
-
Principal Investigator:
- Dorian Schaller, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged over 18
- Patient consulting a general practitioner for a new episode of LBP
- Patients is part of "Delta Network"
Exclusion Criteria:
- Patients that had already consulted their GP for LBP in the last three months (not a new episode)
- Patients unable to give consent and/or unable to answer the questionnaires, i.e. due to Dementia or language difficulties
- Known pregnancy
- Unable or unwilling to provide either a smartphone number or an email address.
- Unable or unwilling to give informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Multi-level intervention
General practioners in this arm will receive the multi-level intervention composed of Stratified care, Healthcare professional education, Patient education and Interprofessional collaboration.
|
|
No Intervention: Usual care
GPs in the control group will have no specific training or intervention.
They will treat patients according to their usual practice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of imaging and opioids prescriptions
Time Frame: At 6 months
|
The number of imaging procedure and opioids prescription in each group will be calculated
|
At 6 months
|
Recruitment procedures
Time Frame: At 6 months
|
The number of patients included in the pilot trial in a 6-month period (number of participants/month/GP)
|
At 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Level of disabling low back pain (LBP)
Time Frame: At 6 weeks, 3 months and 6 months
|
The level of disabling LBP will be measured with the Core Outcome Measure Index (COMI)
|
At 6 weeks, 3 months and 6 months
|
Percentage of LBP patients reaching "acceptable symptom states "
Time Frame: At 6 weeks, 3 months and 6 months
|
the number of patients reaching the "patient acceptable symptom state" (PASS) level as defined on the Core Outcome Measure Index (COMI)
|
At 6 weeks, 3 months and 6 months
|
Level of low back pain intensity
Time Frame: At 6 weeks, 3 months and 6 months
|
The level of low back pain intensity will be measured with the Numerical rating scale (NRS) pain scale.
This scale is from 0 to 10 (higher score equals to higher pain intensity).
|
At 6 weeks, 3 months and 6 months
|
Percentage of patients reaching a low level of low back pain intensity
Time Frame: At 6 weeks, 3 months and 6 months
|
The level of low back pain intensity will be measured with the Numerical rating scale (NRS) pain scale from 0 to 10.
A low level is defined as equal or inferior to 2.0.
|
At 6 weeks, 3 months and 6 months
|
Global perceived change
Time Frame: At 6 weeks, 3 months and 6 months
|
Global perceived change (GPC) by the patient on a 6 points Likert scale ranging from "fully recovered" to "much worse"
|
At 6 weeks, 3 months and 6 months
|
Low back pain trajectory
Time Frame: At 6 months
|
Percentage of patients in each category according to low back pain trajectories
|
At 6 months
|
Direct treatment costs of low back pain
Time Frame: At 6 months
|
The direct treatment costs of LBP will be divided in several categories: GP visits, Specialists visit, pain medication, physiotherapy and investigations (blood tests and imaging studies)
|
At 6 months
|
Working incapacity costs
Time Frame: At 6 months
|
The working incapacity costs will be calculated based on the answers given in the Work Productivity and Activity Impairment Questionnaire (WPAI)
|
At 6 months
|
Beliefs about low back pain in healthcare practitioners
Time Frame: At 6 months
|
Beliefs about low back pain will be evaluated in healthcare practitioners at the end of the intervention to identify the presence of unhelpful beliefs with the Back Pain Attitude Questionnaire (Back-PAQ).
|
At 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Age
Time Frame: enrollment
|
Age
|
enrollment
|
Sex
Time Frame: enrollment
|
Sex
|
enrollment
|
Body mass index
Time Frame: enrollment
|
Body mass index
|
enrollment
|
Comorbidities
Time Frame: enrollment
|
The presence of comorbidities will be evaluated at the start of the study
|
enrollment
|
Tobacco use
Time Frame: enrollment
|
Tobacco use will be evaluated at the start of the study
|
enrollment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Stéphane Genevay, Prof, University Hospital, Geneva
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-00199
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Back Pain, Low
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
University School of Physical Education in WroclawCompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, PosturalPoland
-
Texas Woman's UniversityTexas Physical Therapy AssociationCompletedLow Back Pain | Chronic Low Back Pain | Subacute Low Back PainUnited States
-
University of ParmaKing's College London; Helmholtz Zentrum München; GENOS; Ip Research Consulting... and other collaboratorsUnknownChronic Low Back Pain | Acute Low Back PainUnited States, Australia, Belgium, Croatia, Italy, United Kingdom
-
Ache Laboratorios Farmaceuticos S.A.Unknown
-
Palmer College of ChiropracticDepartment of Health and Human ServicesCompletedChronic Low Back Pain | Subacute Low Back PainUnited States
-
Universität Duisburg-EssenSiemens-BetriebskrankenkasseCompletedChronic Low Back Pain | Recurrent Low Back Pain
-
Karolinska InstitutetCompletedChronic Low Back Pain | Recurrent Low Back Pain | Persistent Low Back PainSweden
-
Apsen Farmaceutica S.A.CompletedLow Back Pain | Low Back Pain, Mechanical | Acute Low Back PainBrazil
Clinical Trials on Implementation of best practice for low back pain in primary care
-
National Center for Complementary and Integrative...Completed
-
Vrije Universiteit BrusselCompletedLow Back Pain | Central Sensitisation | Sensory Profiles | Nociplastic PainBelgium
-
Hasselt UniversityKU Leuven; Université Catholique de Louvain; Universiteit Antwerpen; Axxon - the... and other collaboratorsRecruiting
-
QualiCCareNovo Nordisk A/S; Sanofi; Swiss Society of Endocrinology and Diabetology; Roche... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Primary CareSwitzerland
-
Queen's UniversityCanadian Institutes of Health Research (CIHR)Completed
-
Jordan Miller, PT, PhDCanadian Institutes of Health Research (CIHR)RecruitingBack Pain, LowCanada
-
Aalborg University HospitalSpine Centre of Southern DenmarkRecruiting
-
Laval UniversityQuebec Pain Research NetworkCompleted
-
University of SaskatchewanSaskatchewan Health Research Foundation; Ralston Brothers Grant (Kelsey Trail...Completed
-
Gerencia de Atención Primaria, MadridCompleted